In future studies, we will explore whether evogliptin ameliorate the collagen-integrin-β1/FAK signaling and modulate cytoskeletal remodeling which are associated with arterial stiffness, underlying pathology of cardiovascular diseases including diabetes. The gene discussed is PTK2; the disease is diabetes mellitus.